Boyle Scott N sold CCCC
March 7, 2024 · Form 4 insider transaction
Boyle Scott N sold 115,000 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
115,000
Price
$0.00
Total value
N/A
InsiderBoyle Scott N
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityStock Option (Right to Buy)
Transaction codeD: Disposition to the issuer
Transaction dateMarch 7, 2024
Filing dateMarch 8, 2024
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.; 25% of the shares underlying this option shall vest and become exercisable on January 3, 2023, with the remainder vesting in twelve equal quarterly installments thereafter.